︎
 ︎︎︎ Become a partner of CRSy26 ︎︎︎ Looking for a place to stay during CRSy26? Take a look at our partner hotels! ︎︎︎ Save your seat! Register by 2 October ︎︎︎ Become a partner of CRSy26 ︎︎︎ Looking for a place to stay during CRSy26? Take a look at our  partner hotels! ︎︎︎ Save your seat! Register by 2 October
︎    ︎    ︎    

Rafael Blanco-Domínguez, PhD


Gulbenkian Institute for Molecular Medicine

Lisbon, Portugal

Rafael earned his PhD in 2022 at CNIC (Spain), where he identified T-cell-derived molecules for the diagnosis and therapy of acute heart diseases. As a postdoctoral researcher at GIMM, supported by EMBO and EACR–Mark Foundation fellowships, he leads research programs investigating γδ T cells in the solid tumor microenvironment and harnessing their potential for next-generation immunotherapies.